Recommendations for echocardiography use in the diagnosis and management of cardiac sources of embolism

European Journal of Echocardiography

Volumn 11, Issue 6, 2010, Pages 461-476

  Pepi, Mauro ^a   Evangelista, Arturo ^b   Nihoyannopoulos, Petros ^c   Flachskampf, Frank A ^d   Athanassopoulos, George ^e   Colonna, Paolo ^f   Habib, Gilbert ^g   Ringelstein, E Bernd ^h   Sicari, Rosa ⁱ   Zamorano, Jose Luis ^j   Sitges, Marta ^k   Caso, Pio ^l  

^a UNIVERSITY OF MILAN   (Italy)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

^d UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^e ONASSIS CARDIAC SURGERY CENTER   (Greece)

^f POLICLINICO   (Italy)

^g TIMONE HOSPITAL   (France)

^h UNIVERSITY HOSPITAL MÜNSTER   (Germany)

ⁱ INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^j HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^k UNIVERSITY OF BARCELONA   (Spain)

^l Ospedale Monaldi   (Spain)

more..

Author keywords

Cardioembolic stroke; Transoesophageal echocardiography; Transthoracic echocardiography

Indexed keywords

CEREBROVASCULAR ACCIDENT; CLINICAL PRACTICE; DIAGNOSTIC VALUE; DISEASE SEVERITY; EMBOLISM; HUMAN; MORTALITY; PRIORITY JOURNAL; RECURRENCE RISK; REVIEW; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY;

ATRIAL FIBRILLATION; CARDIOVASCULAR DISEASES; ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; EMBOLISM; EUROPE; FORAMEN OVALE, PATENT; HEART FAILURE; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MYOCARDIAL INFARCTION; RISK ASSESSMENT; RISK FACTORS; SOCIETIES, MEDICAL; STROKE; UNITED STATES;

EID: 77955859271     PISSN: 15252167     EISSN: 15322114     Source Type: Journal    
DOI: 10.1093/ejechocard/jeq045     Document Type: Review

References (113)

1. Ferro JM. Cardioembolic stroke: an update. Lancet Neurol 2003;2:177-188
2. Goldstein LB, Adams R, Alberts MJ, Appel LJ, Brass LM, Bushnell CD et al. Primary prevention of ischemic stroke: a Guideline from the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this Guideline. Stroke 2006;37:1583-1633
3. Sacco RL, Adams R, Albers G, Alberts MJ, Benavente O, Furie K et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: Co-Sponsored by the Council on Cardiovascular Radiology and Intervention: The American Academy of Neurology affirms the value of this guideline. Stroke 2006;37: 577-617. (Pubitemid 43732031)
4. Adams HP Jr, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A et al.; American Heart Association; American Stroke Association Stroke Council; Clinical Cardiology Council; Cardiovascular Radiology and Intervention Council; Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: Guidelines for the early management of adults with ischemic stroke. A guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups. Stroke 2007;38:1655-1711
5. Witt BJ, Brown RD Jr, Jacobsen SJ, Weston SA, Ballman KV, Meverden RA et al. Ischemic stroke after heart failure: a community-based study. Am Heart J 2006; 152:102-109
6. Witt BJ, Gami AS, Ballman KV, Brown RD Jr, Meverden RA, Jacobsen SJ et al. The incidence of ischemic stroke in chronic heart failure: a meta-analysis. J Card Fail 2007;13:489-496
7. Wolf P, Abbott R, Kannel W. Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study. Arch Int Med 1987:147:1561-1564
8. Flachskampf FA, Decoodt P, Fraser AG, Daniel WG, Roelandt JR; Subgroup on Transesophageal Echocardiography and Valvular Heart Disease;Working Group on Echocardiography of the European Society of Cardiology. Recommendations for performing transesoephageal echocardiography. Eur J Echocardiogr 2001;2: 8-21.
9. Hankey GJ, Jamrozik K, Broadhurst RJ, Forbes S, Burvill PW, Anderson CS et al. Five-year survival after first-ever stroke and related prognostic factors in the Perth Community Stroke study. Stroke 2000;31:2080-2086
10. Kolominsky-Rabas PL, Weber M, Gefeller O, Neundoerfer B, Heuschmann PU. Epidemiology of ischemic stroke subtypes according to TOAST criteria: incidence, recurrence, and long-term survival in ischemic stroke subtypes-a population-based study. Stroke 2001;32:2735-2740
11. Lip GY, Lim HS. Atrial fibrillation and stroke prevention. Lancet Neurol 2007;6: 981-993
12. De Jong G, van Raak L, Kessels F, Lodder J. Stroke subtype and mortality: a follow-up study in 998 patients with a first cerebral infarct. J Clin Epidemiol 2003;56:262-268
13. Murtagh B, Smalling RW. Cardioembolic stroke. Curr Atheroscler Rep 2006;8: 310-316
14. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL et al., the TOAST Investigators. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. Stroke 1993;24:35-41.
15. Ringelstein EB, Koschorke S, Holling A, Thron A, Lambertz H, Minale C. Computed tomographic patterns of proven embolic brain infarctions. Ann Neurol 1989;26:759-765
16. Weiller C, Ringelstein EB, ReicheW, Thron A, Buell U. The large striatocapsular infarct. A clinical and pathophysiological entity. Arch Neurol 1990;47:1085-1091
17. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG et al.; American College of Cardiology Foundation; American Heart Association. 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration with the International Society for Heart and Lung Transplantation. J Am Coll Cardiol 2009;53:e1-90.
18. Sen S, Lima JAC, Oppenheimer SM. Changes in cardiac thrombus status after cerebral ischemia. Cerebrovasc Dis 2004;17:175-181
19. Sen S, Laowatana S, Lima J, Oppenheimer SM. Risk factors for intracardiac thrombus in patients with recent ischaemic cerebrovascular events. J Neurol Neurosurg Psychiatry 2004;75;1421-1425
20. Nihoyannopoulos P, Smith GC, Maseri A et al. The natural history of left ventricular thrombus in myocardial infarction: a rationale support of masterly inactivity. J Am Coll Cardiol 1989;14:903-911
21. Weinsaft JW, Kim HW, Shah DJ, Klem I, Crowley AL, Brosnan R et al. Detection of left ventricular thrombus by delayed-enhancement cardiovascular magnetic resonance. J Am Coll Cardiol 2008;52:148-157
22. Senior R, Becher H, Monaghan M, Agati L, Zamorano J, Vanoverschelde JL et al. Contrast echocardiography: evidence-based recommendations by European Association of Echocardiography. Eur J Echocardiogr 2009;10:194-212.
23. Kurt M, Shaikh KA, Peterson L, Kurrelmeyer KM, Shah G, Nagueh SF et al. Impact of contrast echocardiography on evaluation of ventricular function and clinical management in a large prospective cohort. J Am Coll Cardiol 2009;53: 802-810
24. Cioffi G, Pozzoli M, Forni G, Franchini M, Opasich C, Cobelli F et al. Systemic thromboembolism in chronic heart failure. A prospective study in 406 patients. Eur Heart J 1996;17:1381-1389
25. Baker DW, Wright RF. Management of heart failure. IV. Anticoagulation for patients with heart failure due to left ventricular systolic dysfunction. JAMA 1994;272:1614-1618
26. Jugdutt BI, Sivaram CA. Prospective two-dimensional echocardiographic evaluation of left ventricular thrombus and embolism after acute myocardial infarction. J Am Coll Cardiol 1989;13:554-564
27. Fox KF, Cowie MR, Wood DA, Coats AJ, Gibbs JS, Underwood SR et al. Coronary artery disease as the cause of incident heart failure in the population. Eur Heart J 2001;22:228-236
28. Captur G, Nihoyannopoulos P. Left ventricular non-compaction: genetic heterogeneity, diagnosis and clinical course. Int J Cardiol 2009; Epub ahead of print August 5.
29. Oechslin E, Attenhofer Jost CH, Rohas JR, Kaufmann PA, Jenni R. Longterm follow-up of 34 adults with isolated left ventricular noncompaction: a distinct cardiomyopathy with poor prognosis. J Am Coll Cardiol 2000;36:493-500.
30. Fuster V, Gersh BJ, Giuliani ER, Tajik AJ, Brandenburg RO, Frye RL. The natural history of idiopathic dilated cardiomyopathy. Am J Cardiol 1981;47:525-531
31. Katz SD, Marantz PR, Biasucci L, Jondeau G, Lee K, Brennan C et al. Low incidence of stroke in patients with heart failure: a prospective study. Am Heart J 1993;126:141-146
32. Natterson PD, Stevenson WG, Saxon LA, Middlekauff HR, Stevenson LW. Risk of arterial embolization in 224 patients awaiting cardiac transplantation. Am Heart J 1995;129:564-570
33. Go AS, Hylek EM, Phillips KA et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001;285:2370-2375
34. Fuster V, Ryden LE, Cannom DS et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary. Eur Heart J 2006;27:1979-2030.
35. Zabalgoitia M, Halperin JL, Pearce LA, Blackshear JL, Asinger RW, Hart RG, for the Stroke Prevention in Atrial Fibrillation Investigators. Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation. J Am Coll Cardiol 1998;31:1622-1626
36. Fatkin D, Kuchar DL, Thorburn CW, Feneley MP. Transesophageal echocardiography before and during direct current cardioversion of atrial fibrillation: evidence for atrial stunning as a mechanism of thrombo-embolic complications. J Am Coll Cardiol 1994;23:307-316
37. De Luca I, Colonna P, Sorino M, Del Salvatore B, De Luca L. New monodimensional transthoracic echocardiographic sign of left atrial appendage function. J Am Soc Echocardiogr 2007;20:324-332
38. Moreira FC, Miglioransa MH, Hartmann IB, Rohde LE. Left atrial appendage assessment by second harmonic transthoracic echocardiography after an acute ischemic neurologic event. J Am Soc Echocardiogr 2005;18:206-212
39. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 2001;285:2864-2870
40. Hylek EM, Evans-Molina C, Shea C, Henault LE, Regan S. Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation. Circulation 2007;115:2689-2696
41. Bernhardt P, Schmidt H, Hammerstingl C, Lüderitz B, Omran H. Patients with atrial fibrillation and dense spontaneous echo contrast at high risk. A prospective and serial follow-up over 12 months with transesophageal echocardiography and cerebral magnetic resonance imaging. J Am Coll Cardiol 2005;45:1807-1812 (Pubitemid 40789939)
42. Klein AL, Grimm RA, Murray RD, Apperson-Hansen C, Asinger RW, Black IW et al., for the Assessment of Cardioversion Using Transesophageal Echocardiography Investigators. Use of transesophageal ecocardiography to guide cardioversion in patients with atrial fibrillation. N Engl J Med 2001;344:1411-1420
43. Sorino M, Colonna P, De Luca L et al. Post cardioversion transesophageal echocardiography (POSTEC) strategy with the use of Enoxaparin for brief anticoagulation in atrial fibrillation patients: the multicenter POSTEC trial (a pilot study). J Cardiovasc Med 2007;8:1034-1042
44. Stellbrink C, Nixdorff U, Hofmann T, Lehmacher W, Daniel WG, Hanrath P et al. Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation. Circulation 2004;109:997-1003.
45. Klein AL, Murray RD, Grimm RA, Li J, Apperson-Hansen C, Jasper SE et al., for the ACUTE Investigators. Bleeding complications in patients with atrial fibrillation undergoing cardioversion randomized to transesophageal echocardiographically guided and conventional anticoagulation therapies. Am J Cardiol 2003; 92:161-165
46. Klein AL, Murray RD, Becker ED et al. and the ACUTE Investigators. Economic analysis of a transesophageal echocardiography-guided approach to cardioversion of patients with atrial fibrillation: the ACUTE economic data at eight weeks. J Am Coll Cardiol 2004;43:1217-1224
47. Pozzoli M, Selva A, Skouse D, Traversi E, Mancini R, Bana G et al. Visualization of left atrial appendage and assessment of its function by transthoracic second harmonic imaging and contrast-enhanced pulsed Doppler. Eur J Echocardiogr 2002;3: 13-23.
48. Shin AH, Park MY. Left atrial volume is a predictor of atrial fibrillation recurrence after catheter ablation. JASE 2008;21:697-702.
49. Di Salvo G, Caso P, Lo Piccolo R, Fusco A, Martiniello AR, Russo MG et al. Atrial myocardial deformation properties predict maintenance of sinus rhythm after external cardioversion of recent-onset one atrial fibrillation: a color Doppler myocardial imaging and tranthoracic and transesophageal echocardiographic study. Circulation 2005;112:387-395
50. Boyd A, Schiller NB, Ross D, Thomas L. Segmental atrial contraction in patients restored to sinus rhythm after cardioversion for chronic atrial fibrillation: a colour Doppler tissue imaging study. Eur J Echocardiogr 2008;9:12-17.
51. Kaya E, Tokgozoglu L, Aytemir K, Kocabas U, Tulument E, Deveci O et al. Atrial myocardial deformation properties are temporarily reduced after cardioversion for atrial fibrillation and correlate well with atrial appendage function. Eur J Echocardiogr 2008;9:472-477
52. Lechat P, Mas JL, Lascault G, Loron P, Theard M, Klimczac M et al. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 1988;318:1148-1152
53. Webster MWI, Chancellor AM, Smith HJ, Swift DL, Sharpe DN, Bass NM et al. Patent foramen ovale in young stroke patients. Lancet 1988;2:11-12
54. Kerut EK, Norfleet WT, Plotnick GD, Giles TD. Patent foramen ovale: a review of associated conditions and the impact of physiological size. J Am Coll Cardiol 2001;38:613-623
55. Homma S, Sacco RL, Di Tullio MR, Sciacca RR, Mohr JP, PFO in Cryptogenic Stroke Study (PICSS) Investigators. Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study. Circulation 2002;105:2625-2631
56. Flachskampf FA, Daniel WG. Closure of patent foramen ovale: is the case really closed as well? Heart 2005;91:449-450
57. Meier B. Closure of patent foramen ovale: technique, pitfalls, complications, and follow up. Heart 2005;91:444-448
58. Windecker S, Meier B. Is closure recommended for patent foramen ovale and cryptogenic stroke? Patent foramen ovale and cryptogenic stroke: to close or not to close? Closure: what else! Circulation 2008;118:1989-1998
59. Messé S, Kasner S. Is closure recommended for patent foramen ovale and cryptogenic stroke? Patent foramen ovale and cryptogenic stroke: not to close. Circulation 2008;118:1999-2004.
60. Flachskampf FA. CON: the incidental finding of a patent foramen ovale during cardiac surgery: should it always be repaired? Anesth Analg 2007;105:613-614
61. Argenziano M. PRO: the incidental finding of a patent foramen ovale during cardiac surgery. Anesth Analg 2007;105:611-612
62. Di Tullio MR, Sacco RL, Sciacca RR, Jin Z, Homma S. Patent formane ovale and the risk of ischemic stroke in a multiethnic population. J Am Coll Cardiol 2007;49: 797-802.
63. Meissner I, Khandheria BK, Heit JA, Petty GW, Sheps SG, Schwartz GL et al. Patent foramen ovale: innocent or guilty? Evidence from a prospective population-based study. J Am Coll Cardiol 2006;47:440-445
64. Handke M, Harloff A, Olschewski M, Hetzel A, Geibel A. Patent foramen ovale and cryptogenic stroke in older patients. N Engl J Med 2007;357:2262-2268
65. Mas JL, Arquizan C, Lamy C, Zuber M, Cabanes L, Derumeaux G et al., Patent Foramen Ovale and Atrial Septal Aneurysm Study Group. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 2001;345:1740-1746
66. Fox ER, Picard MH, Chow CM, Levine RA, Schwamm L, Kerr AJ. Interatrial septal mobility predicts larger shunts across patent foramen ovales: an analysis with transmitral Doppler scanning. Am Heart J 2003;145:730-736
67. Pinto FJ. When and how to diagnose patent foramen ovale. Should it always be repaired? Heart 2005;91:438-440
68. Clarke NR, Timperley J, Kelion AD, Banning AP. Transthoracic echocardiography using second harmonic imaging with Valsalva manoeuvre for the detection of right to left shunts. Eur J Echocardiogr 2004;5:176-181
69. Agmon Y, Khanderia BK, Meissner I, Schwartz GL, Petterson TM, O' Fallon WM et al. Relation of coronary artery disease and cerebrovascular disease with atherosclerosis of the thoracic aorta in the general population. Am J Cardiol 2002;89: 262-267
70. Tunich PA, Kronzon I. Atheromas of the thoracic aorta: clinical and therapeutic update. J Am Coll Cardiol 2000;35:545-554
71. Amarenco P, Cohen A, Tzourio C. Atherosclerotic disease of the aortic arch as the risk of ischemic stroke. N Engl J Med 1994:331:1474-1479
72. The Stroke Prevention in Atrial Fibrillation Investigators Committee on Echocardiography. TEE correlates of thromboembolism in high-risk patients with nonvalvular atrial fibrillation. Ann Intern Med 1998;128:639-647
73. Meissner I, Khandheria BK, Sheps SG, Schwartz GL, Wiebers DO, Whisnant JP et al. Atherosclerosis of the aorta: risk factor, risk marker, or innocent bystander? J Am Coll Cardiol 2004;44:1018-1024
74. Fukumoto Y, Tsutsui H, Tsuchihashi M, Masumoto A, Takeshita A. The incidence and risk factors of cholesterol embolization syndrome, a complication of cardiac catheterization: a prospective study. J Am Coll Cardiol 2003;42:211-216
75. Van der Linden J, Hadjinikolaou L, Bergman P, Lindblom D. Postoperative stroke in cardiac surgery is related to the location and extent of atherosclerotic disease in the ascending aorta. J Am Coll Cardiol 2001;38:131-135
76. Schwammenthal E, Schwammenthal Y, Tanne D et al. Transcutaneous detection of aortic arch atheromas by suprasternal harmonic imaging. J Am Coll Cardiol 2002;39:1127-1132
77. Montgomery DH, Ververis JJ, Mcgorisk G, Frohwein S, Martin R, Taylor R. Natural history of severe atheromatous disease of the thoracic aorta: a transesophageal echocardiographic study. J Am Coll Cardiol 1996;27:95-101.
78. Avegliano G, Evangelista A, Elorz C, González-Alujas MT, Garc?́a del Castillo H, Soler-Soler J. Acute peripheral arterial ischemia and suspected aortic dissection. Usefulness of transesophageal echocardiography in differential diagnosis with aortic thrombosis. Am J Cardiol 2002;90:674-677
79. Burke A, Jeudy J Jr, Virmani R. Cardiac tumours: an update. Heart 2008;94: 117-123
80. Aggarwal SK, Barik R, Sarma TC, Iyer VR, Sai V, Mishra J et al. Clinical presentation and investigation findings in cardiac myxomas: new insights from the developing world. Am Heart J 2007;154:1102-1107
81. Neragi-Miandoab S, Kim J, Vlahakes G. Malignant tumours of the heart: a review of tumour type, diagnosis and therapy. Clin Oncol 2007;19:748-756
82. Feigenbaum H, ArmstrongWF, Ryan T. Feigenbaum's echocardiography. Masses, Tumors and Source of Embolus. 6th ed. Lippincot Williams and Wilkins; 2005. Chap 21, p702-33.
83. Heidi M, Connolly Jae K. Oh. Braunwalsd's heart disease. Cardiac Tumors and Masses. 8th ed., Elsevier Saunders, 2007. Chap 69, p1815-27.
84. Tornos P, Iung B, Permanyer-Miralda G, Baron G, Delahaye F, Gohlke-Barwolf C et al. Infective endocarditis in Europe: lessons from the Euro Heart Survey. Heart 2005;91:571-575
85. Moreillon P. Infective endocarditis. Lancet 2004;363:139-149
86. Thuny F, Avierinos JF, Tribouilloy C, Giorgi R, Casalta JP, Milandre L et al. Impact of cerebrovascular complications on mortality and neurologic outcome during infective endocarditis: a prospective multicenter study. Eur Heart J 2007;28: 1155-1161
87. Habib G. Embolic risk in subacute bacterial endocarditis. Role of transesophageal echocardiography. Curr Cardiol Rep 2003;5:129-136
88. Di Salvo G, Habib G, Pergola V, Avierinos JF, Philip E, Casalta JP et al. Echocardiography predicts embolic events in infective endocarditis. J Am Coll Cardiol 2001;37:1069-1076
89. Thuny F, Di Salvo G, Belliard O, Avierinos JF, Pergola V, Rosenberg V et al. Risk of embolism and death in infective endocarditis: prognostic value of echocardiography. A prospective multicenter study. Circulation 2005;112:744-754
90. Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Am J Med 1994;96: 200-209
91. Habib G, Hoen B, Tornos P, Thuny F, Prendergast B, Vilacosta I et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): The Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Eur Heart J 2009;30:2369-2413
92. Habib G. Management of infective endocarditis. Heart 2006;92:124-130
93. Di Salvo G, Habib G, Pergola V, Avierinos JF, Philip E, Casalta JP et al. Echocardiography predicts embolic events in infective endocarditis. J Am Coll Cardiol 2001;37:1069-1076
94. Vilacosta I, Graupner C, San Roman JA, Sarria C, Ronderos R, Fernandez C et al. Risk of embolization after institution of antibiotic therapy for infective endocarditis. J Am Coll Cardiol 2002;39:1489-1495
95. Sanfilippo AJ, Picard MH, Newell JB, Rosas E, Davidoff R, Thomas JD et al. Echocardiographic assessment of patients with infectious endocarditis: prediction of risk for complications. J Am Coll Cardiol 1991;18:1191-1199
96. Mugge A, Daniel WG, Frank G, Lichtlen PR. Echocardiography in infective endocarditis: reassessment of prognostic implications of vegetation size determined by the transthoracic and the transoesophageal approach. J Am Coll Cardiol 1989;14:631-638
97. Dickerman SA, Abrutyn E, Barsic B, Bouza E, Cecchi E, Moreno A et al. The relationship between the initiation of antimicrobial therapy and the incidence of stroke in infective endocarditis: an analysis from the ICE Prospective Cohort Study (ICE-PCS). Am Heart J 2007;154:1086-1094
98. Fabri J, Issa VS, Pomerantzeff PMA, Grinberg M, Barretto ACP, Mansur AJ. Timerelated distribution, risk factors and prognostic influence of embolism in patients with left-sided infective endocarditis. Int J Cardiol 2006;110:334-339
99. Roudaut R, Serri K, Lafitte S. Thrombosis of prosthetic heart valves: diagnosis and therapeutic considerations. Heart 2007;93:137-142
100. Tong AT, Roudaut R, Ozkan M, Sagie A, Shahid MS, Pontes Juniur SC et al. Transesophageal echocardiography improves risk assessment of thrombolysis of prosthetic valve thrombosis: results of the international PRO-TEE registry. J Am Coll Cardiol 2004;43:77-84.
101. Alpert JS. The thrombosed prosthetic valve. Current recommendations based on evidence from the literature. J Am Coll Cardiol 2003;41:659-660
102. Khairy P, O'Donnell CP, Landzberg MJ. Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli: a systematic review. Ann Intern Med 2003;139:753-760
103. Freed LA, Levy D, Levine RA, Larson MG, Evans JC, Fuller DL et al. Prevalence and clinical outcomes of mitral valve prolapse. N Engl J Med 1999;341:1-7.
104. Freed LA, Benjamin EJ, Levy D, Larson MG, Evans JC, Fuller DL et al. Mitral valve prolapse in the general population: the benign nature of echocardiographic features in the Framingham Heart Study. J Am Coll Cardiol 2002;40:1298-1304
105. Gilon D, Buonannd F, Joffe M, Leavitt M, Marshall JE, Kistler JP et al. Lack of evidence of an association between mitral-valve prolapse and stroke in young patients. N Engl J Med 1999;341:8-13.
106. Nishimura RA, McGoon MD. Perspectives in mitral valve prolapse. N Engl J Med 1999;341:48-50.
107. Cardiogenic brain embolism. The second report of the Cerebral Embolism Task Force. Arch Neurol 1989;46:727-743
108. Freed LA, Levy P, Levine RA, Evans JC, Larson MG, Fuller DL et al. Mitral valve prolapse and atrial septal aneurysm: an evaluation in the Framingham Heart Study. Am J Cardiol 2002;89:1326-1329
109. Fox C, Vasan R, Levy D, O'Donnel C, D'Agostino R, Benjamin E. Mitral annular calcification predicts cardiovascular morbidity and mortality: the Framingham Heart Study. Circulation 2003;107:1492-1496
110. Schaer BA, Zellweger MJ, Cron TA, Kaiser CA, Osswald S. Value of routine Holter monitoring for the detection of paroxysmal atrial fibrillation in patients with cerebral ischemic event. Stroke 2004;35:e68-70.
111. Vandenbrouke E, Thijs VN. Diagnostic and therapeutic impact of ambulatory electrocardiography in acute stroke. Acta Neurol Belg 2004;104:27-31.
112. Kirchhof P, Auricchio A, Bax J, Crijns H, Camm J, Diener HC et al. Outcome parameters for trials in atrial fibrillation: executive summary. Recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork (AFNET) and the European Heart Rhythm Association (EHRA). Eur Heart J 2007;28:2803-2817 (Pubitemid 350135529)
113. Jabaudon D, Sztajzel J, Sievert K, Landis T, Sztajzel R. Usefulness of ambulatory 7-day ECG monitoring for the detection of atrial fibrillation and flutter after acute stroke and transient ischemic attack. Stroke 2004;35:1647-1651